EP1153022A4 - Inhibiteurs de protease - Google Patents

Inhibiteurs de protease

Info

Publication number
EP1153022A4
EP1153022A4 EP00910222A EP00910222A EP1153022A4 EP 1153022 A4 EP1153022 A4 EP 1153022A4 EP 00910222 A EP00910222 A EP 00910222A EP 00910222 A EP00910222 A EP 00910222A EP 1153022 A4 EP1153022 A4 EP 1153022A4
Authority
EP
European Patent Office
Prior art keywords
prothease
inhibitors
prothease inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00910222A
Other languages
German (de)
English (en)
Other versions
EP1153022A1 (fr
Inventor
Robert Wells Marquis Jr
Daniel Frank Veber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP1153022A1 publication Critical patent/EP1153022A1/fr
Publication of EP1153022A4 publication Critical patent/EP1153022A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16—Eight-membered rings
    • C07D313/18—Eight-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
EP00910222A 1999-02-19 2000-02-17 Inhibiteurs de protease Withdrawn EP1153022A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12069999P 1999-02-19 1999-02-19
US120699P 1999-02-19
PCT/US2000/004133 WO2000049011A1 (fr) 1999-02-19 2000-02-17 Inhibiteurs de protease

Publications (2)

Publication Number Publication Date
EP1153022A1 EP1153022A1 (fr) 2001-11-14
EP1153022A4 true EP1153022A4 (fr) 2002-03-27

Family

ID=22392011

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00910222A Withdrawn EP1153022A4 (fr) 1999-02-19 2000-02-17 Inhibiteurs de protease

Country Status (8)

Country Link
EP (1) EP1153022A4 (fr)
JP (1) JP2002537297A (fr)
AU (1) AU3235100A (fr)
CO (1) CO5271679A1 (fr)
DZ (1) DZ3083A1 (fr)
HK (1) HK1042695A1 (fr)
PE (1) PE20001486A1 (fr)
WO (1) WO2000049011A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
US6596715B1 (en) 1999-11-10 2003-07-22 Smithkline Beecham Corporation Protease inhibitors
JP2003513972A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
HUP0300068A2 (en) 2000-03-21 2003-05-28 Smithkline Beecham Corp Protease inhibitors, their preparation, their use and pharmaceutical compositions containing them
ATE323083T1 (de) * 2000-11-17 2006-04-15 Medivir Ab Cystein protease inhibitoren
CA2428863A1 (fr) * 2000-11-17 2002-05-23 Medivir Uk Limited Inhibiteurs de cysteine protease
ATE338803T1 (de) * 2003-05-27 2006-09-15 Merck Patent Gmbh Pyranderivative mit exocyclischer doppelbindung
DE502004001563D1 (de) * 2003-05-27 2006-11-09 Merck Patent Gmbh Pyranderivate
EP1757284A1 (fr) 2005-08-25 2007-02-28 Santhera Pharmaceuticals (Schweiz) AG Utilisation de la N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) pour la prévention ou le traitement de la dystrophie musculaire

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
AU6252794A (en) * 1993-03-03 1994-09-26 Eli Lilly And Company Balanoids
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
AR013079A1 (es) * 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0049011A1 *

Also Published As

Publication number Publication date
JP2002537297A (ja) 2002-11-05
CO5271679A1 (es) 2003-04-30
EP1153022A1 (fr) 2001-11-14
AU3235100A (en) 2000-09-04
WO2000049011A1 (fr) 2000-08-24
DZ3083A1 (fr) 2004-06-02
PE20001486A1 (es) 2001-02-08
HK1042695A1 (zh) 2002-08-23

Similar Documents

Publication Publication Date Title
GB9900416D0 (en) Inhibitors
IL146518A0 (en) Metalloprotease inhibitors
EG23979A (en) Renin inhibitors
IL148820A0 (en) Fab i inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
HK1042695A1 (zh) 蛋白酶抑制劑
EP1235577A4 (fr) Inhibiteurs de protease
GB9924522D0 (en) Enzyme inhibitors
EP1232155A4 (fr) Inhibiteurs de protease
EP1229912A4 (fr) Inhibiteurs de protease
EP1231921A4 (fr) Inhibiteurs de proteases
EP1229915A4 (fr) Inhibiteurs de protease
EP1229914A4 (fr) Inhibiteurs de protease
EP1173429A4 (fr) Inhibiteurs de protease
EP1233771A4 (fr) Inhibiteurs de protease
EP1351930A4 (fr) Inhibiteurs de la protease
EP1229911A4 (fr) Inhibiteurs de proteases
HK1043534A1 (zh) 蛋白酶抑制劑
GB2389113B (en) B-secretase inhibitor
EP1231923A4 (fr) Inhibiteurs de protease
EP1231922A4 (fr) Inhibiteurs de protease
EP1232154A4 (fr) Inhibiteurs de protease
EP1189618A4 (fr) Inhibiteurs de la thrombine
GB9900413D0 (en) Inhibitors
GB9917294D0 (en) Inhibitors

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010711

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020208

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 313/04 A, 7C 07D 333/70 B, 7C 07D 241/36 B, 7C 07D 209/42 B, 7A 61K 31/336 B, 7A 61K 31/381 B, 7A 61K 31/498 B, 7A 61K 31/404 B, 7C 07D 498/04 B, 7C 07D 313/18 B, 7C 07D 409/12 B, 7C 07D 407/12 B, 7C 07D 405/12 B, 7A 61K 31/38 B, 7A 61K 31/34 B, 7A 61K 31/40 B, 7A 61K 31/47 B, 7A 61K 31/495 B

17Q First examination report despatched

Effective date: 20020513

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021126

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1042695

Country of ref document: HK